VEVYX
Price
$52.21
Change
-$0.41 (-0.78%)
Updated
Sep 20 closing price
VMVAX
Price
$86.17
Change
-$0.37 (-0.43%)
Updated
Sep 20 closing price
Ad is loading...

VEVYX vs VMVAX

Header iconVEVYX vs VMVAX Comparison
Open Charts VEVYX vs VMVAXBanner chart's image
Victory Sycamore Established Value Y
Price$52.21
Change-$0.41 (-0.78%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$86.17
Change-$0.37 (-0.43%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
VEVYX vs VMVAX Comparison Chart
Loading...
VS
VEVYX vs. VMVAX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VEVYX is a Buy and VMVAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 30.5B vs. VEVYX (19.5B). VMVAX pays higher dividends than VEVYX: VMVAX (2.14) vs VEVYX (1.26). VEVYX was incepted earlier than VMVAX: VEVYX (12 years) vs VMVAX (13 years). VEVYX is a more actively managed with annual turnover of: 28.00 vs. VMVAX (22.00). VMVAX has a lower initial minimum investment than VEVYX: VMVAX (3000) vs VEVYX (1000000). VMVAX annual gain was more profitable for investors over the last year : 25.35 vs. VEVYX (19.73). VMVAX return over 5 years is better than : 48.82 vs. VEVYX (40.78).
VEVYXVMVAXVEVYX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years13 years-
Gain YTD14.13514.94695%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets19.5B30.5B64%
Annual Yield % from dividends1.262.1459%
Returns for 1 year19.7325.3578%
Returns for 3 years12.6620.7161%
Returns for 5 years40.7848.8284%
Returns for 10 years63.98100.8863%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AUUD0.790.01
+0.67%
Auddia
CTLT60.00-0.11
-0.18%
CATALENT
JAMF18.49-0.09
-0.48%
Jamf Holding Corp
ARCT20.61-0.41
-1.95%
Arcturus Therapeutics Holdings
ANVS8.47-0.17
-1.97%
Annovis Bio